Riskpilot← Back to searchSign inGet full accessUmeå Huddiagnostik AB
ABIn liquidationOrg 5590724125Medical specialists activities · NACE 8622Est. 20160 employees
Revenue 2025
SEK 0
EBITDA margin
—
+32% vs 2024
Equity ratio
77.8%
Financial strength
Net profit 2025
SEK -14K
+30% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | +32% |
| Net profit | SEK -14K | +30% |
| Total assets | SEK 63K | -32% |
| Equity | SEK 49K | -22% |
| Employees | 0 | — |
Legal name
Umeå Huddiagnostik AB
Org number
5590724125
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 augusti 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva medicinsk konsulting, histopatologisk laboratorieverksamhet, investering i fastigheter, äga och förvalta fastigheter och värdepapper, samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 9 | 687 | 140 | 2 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | 646 | 106 | −19 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −8 | 646 | 106 | −19 | −13 |
| Net financials | 101 | — | 2 | −1 | — |
| Profit before tax | 93 | 646 | 108 | −20 | −14 |
| Tax | −0 | −126 | −22 | −0 | −0 |
| Net profit | 93 | 520 | 86 | −20 | −14 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 168 | 735 | 324 | 92 | 63 |
| Equity | 147 | 576 | 163 | 63 | 49 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 | 158 | 162 | 29 | 14 |
| Total debt | 21 | 158 | 162 | 29 | 14 |
EBITDA margin
-1300000.0%
This company
15.8%
Market median
-8227948% vs market
20212025
Equity ratio
77.8%
This company
38.2%
Market median
+104% vs market
20212025
Return on equity
-28.6%
This company
18.4%
Market median
-255% vs market
20212025
Net profit margin
-1400000.0%
This company
8.1%
Market median
-17284051% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PS Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Umeå Huddiagnostik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Stefan Österlund | Liquidator | 0 companies |
| Maja Jenny Linnéa Näsström | Deputy Board Member | 0 companies |
| Daniel Marcus Lieb Nosek | Board of Directors | 0 companies |